MPs slam DH and NHS ‘complacency’ over lack of GPs
The Department of Health (DH) and NHS England have been ‘complacent’ about the health service’s ability to cope with rising demand for GPs, according to a new report.
Read MoreAuthor: George Underwood
Novartis’ precision leukaemia drug gets breakthrough status
Novartis’ precision medicine for acute myeloid leukaemia (AML) has been granted breakthrough therapy designation by the FDA.
Read MoreT-cell hype ignoring cost and safety concerns, say experts
Experts have cautioned that the hype surrounding T-cell cancer therapies could be too optimistic and overlooks the cost and safety concerns surrounding the treatment.
Read MoreNHS trusts facing £2.3bn deficit
Healthcare think tank the King’s Fund has warned that NHS trusts in England could have a deficit of £2.3 billion by the end of the year.
Read MoreZika vaccine effective in mice
Inovio’s Zika virus vaccine candidate has demonstrated “robust and durable immune responses” in mice, raising hopes for a way to tackle the rapid spread of the disease.
Read More- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
- CatalYm begins phase 2b trial of visugromab in second-line liver cancer treatment
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
